Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

sdlittle

Rank: President [?]

Points: 1633 [?]

Votes: 31 Score: 2.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

RE: Questions ... correction

posted on Apr 07, 2006 03:13AM

I should have said ``I guess it`s pretty likely that OUR CUT OF the Fujitsu settlement was at least $15MM.`` This is assuming that the company would not dip into their previous cash holding to cover a portion of the dividend. The actual licensing agreement would need to be around $30MM for this to be true.